Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
AssigneeBiogaia AB
InventorsBo Mollstam, Eamonn Connolly
Life of this patent
Estimating the term…
Abstract
New strains of Lactobacillus that have been selected for their capability of improved reduction the number of Streptococcus mutans in the mouth of mammals through inhibiting activity in combination with better binding to the oral mucins and dental plaque, thereby preventing, reducing or treating dental caries, and products derived from said strains, including agents for treatment or prophylaxis of caries for administration to humans.
Claims21
A biologically pure culture of Lactobacillus reuteri strain FJ1 “Prodentis” (ATCC PTA-5289).
A biologically pure culture of Lactobacillus reuteri strain FJ3 (ATCC PTA-5290).
A biologically pure culture of Lactobacillus selected for its ability of reducing the number of Streptococcus mutans in the mouth for prophylaxis or treatment of dental caries in mammals using a selection assay of inhibiting activity in combination with good binding to oral mucins.
A product for inhibiting the growth of dental caries bacteria, comprising cells of at least one strain of Lactobacillus reuteri selected to have inhibitory activity against cariogenic bacteria in combination with good binding to oral mucins.
A method for producing a product that is anti-cariogenic, comprising adding to the product cells of at least one strain of Lactobacillus reuteri selected to have inhibitory activity against cariogenic bacteria in combination with good binding to oral mucins.
Dependencies are inferred from the claim text.